Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 16.8.2021 | EN | Official Journal of the European Union | C 329/40 |

---

Action brought on 30 June 2021 — Biogena v EUIPO — Alter Farmacia (NUTRIFEN AGNUBALANCE)

(Case T-370/21)

(2021/C 329/53)

Language of the case: English

Parties

Applicant: Biogena GmbH & Co KG (Salzburg, Austria) (represented by: I. Schiffer, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Alter Farmacia, SA (Madrid, Spain)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: International registration designating the European Union in respect of the word mark NUTRIFEN AGNUBALANCE — International registration designating the European Union No 1 430 349

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 April 2021 in Case R 1208/2020-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | grant the registration of the IR 1 430 349 for all applied goods; |

|  |  |
| --- | --- |
| — | order EUIPO and Alter Farmacia, S. A. to pay the costs. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 8 (1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of Article 94 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)